Drugs and Drug-like compounds: Discriminating Approved Pharmaceuticals from Screening-Library Compounds.

Schierz, A. C. and King, R. D., 2009. Drugs and Drug-like compounds: Discriminating Approved Pharmaceuticals from Screening-Library Compounds. In: Pattern Recognition in Bioinformatics. Berlin/Heidelberg: Springer, pp. 331-343.

This is the latest version of this eprint.

Full text not available from this repository.

DOI: 10.1007/978-3-642-04031-3_29

Abstract

Compounds in drug screening-libraries should resemble pharmaceuticals. To operationally test this, we analysed the compounds in terms of known drug-like filters and developed a novel machine learning method to discriminate approved pharmaceuticals from “drug-like” compounds. This method uses both structural features and molecular properties for discrimination. The method has an estimated accuracy of 91% in discriminating between the Maybridge HitFinder library and approved pharmaceuticals, and 99% between the NATDiverse collection (from Analyticon Discovery) and approved pharmaceuticals. These results show that Lipinski’s Rule of 5 for oral absorption is not sufficient to describe “drug-likeness” and be the main basis of screening-library design.

Item Type:Book Section
ISBN:978-3-642-04030-6
Series Name:Lecture Notes in Computer Science
Number:5780/2
Series Name:Lecture Notes in Computer Science
Additional Information:Paper given at 4th IAPR International Conference on Pattern Recognition in Bioinformatics, 7-9 September 2009
Subjects:Generalities > Computer Science and Informatics > Artificial Intelligence
Science > Chemistry
Group:School of Design, Engineering & Computing > Smart Technology Research Centre
ID Code:13335
Deposited By:Dr Amanda C. Schierz LEFT
Deposited On:21 Mar 2010 19:32
Last Modified:07 Mar 2013 15:23
Repository Staff Only -
BU Staff Only -
Help Guide - Editing Your Items in BURO